Luxxamed GmbH -About us
Luxxamed GmbH is a medical technology company based in Kassel in northern Hesse. The company currently has 6 employees. The company was founded in 2011 and specializes in the pain therapy systems market.
In 2014 a quality management system according to DIN EN ISO 13485 was introduced and certified by TÜV Nord.
Luxxamed GmbH develops and produces devices for physical pain therapy with microcurrents and LED light. The devices are used in acute and chronic pain therapy and the treatment of neurological complaints. The devices are mainly used by general practitioners, physiotherapists and alternative practitioners.
We understand working with medical technology as working with people and health. For us, maintaining health also includes conscious and careful use of the environment and resources.
Our characteristics & goals: Experience I Quality I Professionalism I Benefit
“Just satisfied customers is not enough for us! We want enthusiastic customers! “
Patrick Walitschek, CEO
Research and Development
Research and developments (including with the Fraunhofer Institute) have been running in the background for several years to make this medical concept even more successful and easier for the user. The product quality was always in the foreground. The result was the Luxxamed HD1000. This ties in with the successes with the Clinic-Master and Vital-Master. However, the medical and therapeutic philosophy at Luxxamed is different. Derived from the principles of Kybernetic, completely new possibilities arise for users and patients.
1999 to 2011
From 1999 to 2011 was the Clinic Master professional from Walitschek Medizintechnik GmbH, under the direction of Prof. hc Bernd Walitschek, one of the most widely used therapy systems for biological cell regulation (BCR therapy ©) in Europe. ( BCR therapy ). This therapy system is used in professional sport around the world, for example at the ATP in tennis, the German Football Association and other professional athletes.
Then came the in 2011 Luxxamed HD1000 on the market.
Under the direction of Patrick Walitschek (Managing Director of Luxxamed GmbH), new research projects are already pending or are already being carried out. Luxxamed GmbH works according to DIN EN ISO 9001 and DIN EN ISO 13485 for manufacturers of medical devices and is internationally positioned. The quality management system was certified and confirmed by TÜV-Nord in summer 2014. In 2013, a previously unique comparative study (a comparison of red and blue LED light in use on human cells) was published in collaboration with the Fraunhofer Institute. Here the “nanophoton therapy” of the Luxxamed was applied to the biological and medical effectiveness checked and at the same time in their postulated effect scientific confirmed.